Work

25 The use of EBV-specific cytotoxic T lymphocytes as adjuvant therapy post stem cell transplant for relapsed EBV-positive Hodgkin disease

Year: 2003
Type: article
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2013662863
FWCI: 0.138
Cites:
Cited by: 1
Related to: 10